Aldatu’s variant genotyping test differentiates between Covid-19 variants
The PANDAA qDx SARS-CoVar is designed to differentiate between Omicron, Delta, and other variants of concern
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Dec 21
The PANDAA qDx SARS-CoVar is designed to differentiate between Omicron, Delta, and other variants of concern
13 Dec 21
Copley is a private investment firm with offices in Boston and Denver. Copley focuses on partnering with growing,…
10 Dec 21
The approval allows to use the Oncomine Dx Target Test to detect NSCLC patients whose tumors carry EGFR…
10 Dec 21
The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth…
10 Dec 21
Point of Care Facilities Authorized to Use GenBody’s Nasopharyngeal and Anterior Nasal Swab Test Kits to Test People…
10 Dec 21
Philips’ next-generation nSIGHT Plus imaging architecture and new X5-1c Transthoracic Transducer drive breakthrough cardiac imaging performance
09 Dec 21
Foundation Medicine’s tissue-based test is said to be the first and only CGP test to receive FDA approval…
09 Dec 21
Using positive SARS-CoV-2 samples, the NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 detects mutations associated with all SARS-CoV-2 variants, including…
08 Dec 21
The funding will help the company to accelerate the commercialisation of its blood test for colorectal cancer (CRC)…
08 Dec 21
HealthPulse@home provides a faster, less expensive, hassle-free option for laboratories looking to offer COVID-19 specimen collection kits in…